Drawing for UNISANTIS

USPTO serial 79133104

UNISANTIS

Reviewed by CopyMark Law Group

Reg. 4676939Status 404
Filing date
Status date
Registration date
Jan 27, 2015
Examiner
POLZER, NATALIE M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with UNISANTIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christina L. Brown

Christina L. Brown McDonnell Boehnen Hulbert & Berghoff LLP300 S. Wacker Dr.Ste. 3100Chicago, IL 60606

Goods and services

ClassDescriptionStatusFirst use
001Active plant agents and plant extracts in particular for research purposesSECTION 71 - CANCELLED—
003Cosmetics; soaps; perfumery; essential oils; hair lotions and cosmetics; dentifrices; non-medicated products for dental care, namely, toothpaste, mouth wash, dental rinse, chewing gum for dental care and dental spraySECTION 71 - CANCELLED—
005Nutritional supplements for medical use; non-medical nutritional supplements of animal origin; non-medical cereal-based nutritional supplements; non-medical nutritional supplements based on fruits and vegetables; phytopharmaceutical medicines for the treatment of human and animal diseases, namely, cancer, neurological, inflammatory, cardiovascular, immunological, gastro-intestinal and infective diseases and diseases of the mucosa; active plant agents and plant extracts for medical use; medical, pharmaceutical, veterinary and sanitary products for the treatment of human and animal diseases, namely, cancer, neurological, inflammatory, cardiovascular, immunological, gastro-intestinal and infective diseases and diseases of the mucosa; dietetic substances for medical use, namely, herbs, fruits, spices, vegetables, algae, fungi or in the nature of minerals, trace-elements, vitamins, micro-nutrients, food for babies; adjuvants for medical use; amino acids for medical use; anesthetics for non-surgical use; analgesics; vermifuges; antibiotics; logs for pharmaceutical use; biological preparations for the treatment of human and animal diseases, namely, cancer, neurological, inflammatory, cardiovascular, immunological, gastro-intestinal and infective diseases and diseases of the mucosa; chemical preparations for medical use, namely, for the treatment of human and animal diseases, namely, cancer, neurological, inflammatory, cardiovascular, immunological, gastro-intestinal and infective diseases and diseases of the mucosa; chemical reagents for medical or veterinary use; chemico-pharmaceutical preparations for the treatment of human and animal diseases, namely, cancer, neurological, inflammatory, cardiovascular, immunological, gastro-intestinal and infective diseases and diseases of the mucosa; ferments for pharmaceutical use; hormones for medical use; medical infusions for the treatment of human and animal diseases, namely, cancer, neurological, inflammatory, cardiovascular, immunological, gastro-intestinal and infective diseases and diseases of the mucosa; medicines for dental use; medicines for the treatment of human and animal diseases, namely, cancer, neurological, inflammatory, cardiovascular, immunological, gastro-intestinal and infective diseases and diseases of the mucosa; radiological contrast substances for medical use; chemical reagents for medical or veterinary use; steroids, vitamins and vitamin preparations; medical preparations for slimmingSECTION 71 - CANCELLED—
029Meat, fish, poultry and game, not live; meat extracts; preserved, dried and cooked fruits and vegetables; unflavoured and unsweetened gelatins; jellies, jams, fruit compote, eggs, cheeses, milk and dairy products excluding ice cream, ice milk and frozen yogurt; olive oil and other edible oils and fats; cooked dishes and semi-cooked dishes consisting primarily of meat, fish or poultrySECTION 71 - CANCELLED—
030Coffee, tea, cocoa, sugar, rice, tapioca, sago, artificial coffee; flour and preparations made from cereals, namely, cereal-based snack foods, cereal bars, cereal capsules, cereal oil capsules, cereal powders, cereal granulates and cereal flakes; bread, fine bakery and pastry products, ice; honey, treacle; yeast, baking powder, salt, mustard, vinegar, sauces, spices, ice for refrigerating; plant-based cooked dishes and semi-cooked dishes consisting primarily of cooked or semi-cooked whole grainsSECTION 71 - CANCELLED—
042Scientific and technological services, namely, research and development services in the field of pharmaceuticals; research and development of new products for others; medical research; scientific research and industrial research in the field of pharmaceuticals; scientific and technological research and design services in the pharmaceutical and biotechnology fields; pharmaceutical industrial research and analysis services; services provided by a pharmaceutical laboratory; pharmaceutical research and development; scientific services, namely, development of medicines, active agents and vaccines; scientific services, namely, development of food supplementsSECTION 71 - CANCELLED—
044Pharmacy advice in the nature of pharmaceutical advice; preparation of pharmaceutical formulas for pharmaceutical use; preparation of plant extracts for pharmaceutical useSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 27, 2023DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Nov 27, 2023DETHDEATH OF INTERNATIONAL REGISTRATION—
Jul 18, 2022RFNTREFUSAL PROCESSED BY IB—
Aug 28, 2021DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Aug 28, 2021DETHDEATH OF INTERNATIONAL REGISTRATION—
Aug 13, 2021C71TCANCELLED SECTION 71—
May 15, 2021ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Aug 28, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 1, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 1, 2015FIMPFINAL DISPOSITION PROCESSED—
Apr 27, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 27, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 15, 2015OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Dec 31, 2014OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 31, 2014OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 18, 2014NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 11, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 8, 2014GPNXNOTIFICATION PROCESSED BY IB—
Oct 22, 2014OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 22, 2014OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 22, 2014NPUBNOTICE OF PUBLICATION—
Oct 6, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 1, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 26, 2014CNEAEXAMINERS AMENDMENT MAILED—
Sep 26, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Sep 26, 2014CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 18, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 18, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 18, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 16, 2014RFNTREFUSAL PROCESSED BY IB—
Mar 18, 2014CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 14, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 19, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 19, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 12, 2014ALIEASSIGNED TO LIE—
Feb 5, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 7, 2013RFNTREFUSAL PROCESSED BY IB—
Aug 21, 2013RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 21, 2013RFRRREFUSAL PROCESSED BY MPU—
Aug 21, 2013RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 20, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 20, 2013DOCKASSIGNED TO EXAMINER—
Jul 30, 2013MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 26, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 25, 2013REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance